Eton Pharmaceuticals, Inc. Business Operations Contracts & Agreements

7 Contracts & Agreements

Browse by Subcategory

Development Agreements (4 contracts)
Sales Agreements (3)

Recent Contracts

Development, Supply and Commercialization Agreement (CT-100) dated November 7, 2017 between Amphastar Pharmaceuticals, Inc. and the Registrant (Filed With SEC on October 18, 2018)
Exclusive Sales and Marketing Agreement (EM-100) dated August 11, 2017 between Eyemax, LLC and the Registrant (Filed With SEC on October 18, 2018)
Development, Supply and Commercialization Agreement (CT-100) dated November 7, 2017 (Filed With SEC on September 25, 2018)
Exclusive Sales and Marketing Agreement (EM-100) dated August 11, 2017 between Eyemax, LLC and the Registrant (Filed With SEC on September 25, 2018)
Development, Supply and Commercialization Agreement (CT-100) dated November 7, 2017 (Filed With SEC on August 10, 2018)
Exclusive Sales and Marketing Agreement (EM-100) dated August 11, 2017 between Eyemax, LLC and the Registrant (Filed With SEC on August 10, 2018)
Exclusive Development and Supply Agreement (DS-100) dated July 9, 2017 between Andersen Pharma, LLC and the Registrant (Filed With SEC on August 10, 2018)